Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Nucleoside Derivatives - 2’-Modified nucleosides; 8-Modified purine nucleosides; Halo-nucleosides
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | 5 days | Inquiry | |
10 mg | 5 days | Inquiry | |
25 mg | 5 days | Inquiry | |
50 mg | 5 days | Inquiry | |
100 mg | 5 days | Inquiry | |
500 mg | 5 days | Inquiry |
Description | Nucleoside Derivatives - 2’-Modified nucleosides; 8-Modified purine nucleosides; Halo-nucleosides |
Molecular Weight | 316.7 |
Formula | C11H13ClN4O5 |
CAS No. | 1106012-39-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
8-Chloro-2’-beta-C-methyl inosine 1106012-39-8 inhibitor inhibit